INS and Hypoglycemia: GLP-1 RAs mimic the function of natural GLP-1 by enhancing insulin secretion in response to glucose and inhibiting excessive glucagon secretion, leading to a decrease in HbA1c, FPG, and postprandial glucose excursions, all without the risk of hypoglycemia [22].